SLC25A53
gene geneOn this page
Summary
SLC25A53 (solute carrier family 25 member 53, HGNC:31894) is a protein-coding gene on chromosome Xq22.2, encoding Solute carrier family 25 member 53 (Q5H9E4).
Predicted to enable NAD transmembrane transporter activity. Predicted to be involved in NAD transmembrane transport. Located in mitochondrion.
Source: NCBI Gene 401612 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 113 total
- MANE Select transcript:
NM_001012755
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31894 |
| Approved symbol | SLC25A53 |
| Name | solute carrier family 25 member 53 |
| Location | Xq22.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000269743 |
| Ensembl biotype | protein_coding |
| OMIM | 300941 |
| Entrez | 401612 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 10 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000467290, ENST00000594199, ENST00000905741, ENST00000905742, ENST00000905743, ENST00000926422, ENST00000926423, ENST00000926424, ENST00000926425, ENST00000926426, ENST00000944286
RefSeq mRNA: 1 — MANE Select: NM_001012755
NM_001012755
CCDS: CCDS35363
Canonical transcript exons
ENST00000594199 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002979089 | 104099214 | 104105288 |
| ENSE00003190858 | 104156878 | 104157009 |
Expression profiles
Bgee: expression breadth ubiquitous, 160 present calls, max score 87.67.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.5176 / max 114.8289, expressed in 1775 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 200032 | 7.1088 | 1765 |
| 200031 | 0.9823 | 543 |
| 200030 | 0.4265 | 228 |
Top tissues by expression
244 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 87.67 | gold quality |
| islet of Langerhans | UBERON:0000006 | 84.17 | gold quality |
| monocyte | CL:0000576 | 82.71 | gold quality |
| leukocyte | CL:0000738 | 82.42 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 81.19 | gold quality |
| sural nerve | UBERON:0015488 | 80.47 | gold quality |
| rectum | UBERON:0001052 | 79.85 | gold quality |
| vermiform appendix | UBERON:0001154 | 78.68 | gold quality |
| colonic epithelium | UBERON:0000397 | 78.66 | gold quality |
| gall bladder | UBERON:0002110 | 78.50 | gold quality |
| popliteal artery | UBERON:0002250 | 78.05 | gold quality |
| tibial artery | UBERON:0007610 | 78.00 | gold quality |
| pancreas | UBERON:0001264 | 77.49 | gold quality |
| aorta | UBERON:0000947 | 76.88 | gold quality |
| right coronary artery | UBERON:0001625 | 76.78 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 76.63 | gold quality |
| left coronary artery | UBERON:0001626 | 76.49 | gold quality |
| granulocyte | CL:0000094 | 76.38 | gold quality |
| stromal cell of endometrium | CL:0002255 | 76.31 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 76.24 | gold quality |
| adrenal tissue | UBERON:0018303 | 76.00 | gold quality |
| thoracic aorta | UBERON:0001515 | 75.84 | gold quality |
| ascending aorta | UBERON:0001496 | 75.72 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 75.51 | gold quality |
| body of pancreas | UBERON:0001150 | 75.49 | gold quality |
| lymph node | UBERON:0000029 | 75.17 | gold quality |
| muscle of leg | UBERON:0001383 | 74.90 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 74.65 | gold quality |
| coronary artery | UBERON:0001621 | 74.56 | gold quality |
| left adrenal gland | UBERON:0001234 | 74.52 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.96 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
219 targeting SLC25A53, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
Literature-anchored findings (GeneRIF, showing 1)
- Compares and contrasts all the known human SLC25A* genes and includes functional information. (PMID:23266187)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Slc25a53 | ENSMUSG00000044348 |
| rattus_norvegicus | Slc25a53 | ENSRNOG00000069699 |
Paralogs (49): SLC25A13 (ENSG00000004864), SLC25A5 (ENSG00000005022), SLC25A39 (ENSG00000013306), SLC25A40 (ENSG00000075303), SLC25A3 (ENSG00000075415), SLC25A43 (ENSG00000077713), SLC25A24 (ENSG00000085491), SLC25A1 (ENSG00000100075), SLC25A17 (ENSG00000100372), SLC25A14 (ENSG00000102078), SLC25A15 (ENSG00000102743), SLC25A11 (ENSG00000108528), UCP1 (ENSG00000109424), SLC25A36 (ENSG00000114120), SLC25A12 (ENSG00000115840), SLC25A2 (ENSG00000120329), SLC25A51 (ENSG00000122696), SLC25A16 (ENSG00000122912), SLC25A35 (ENSG00000125434), SLC25A19 (ENSG00000125454), SLC25A23 (ENSG00000125648), SLC25A47 (ENSG00000140107), SLC25A52 (ENSG00000141437), SLC25A38 (ENSG00000144659), SLC25A26 (ENSG00000144741), SLC25A48 (ENSG00000145832), SLC25A37 (ENSG00000147454), SLC25A25 (ENSG00000148339), SLC25A31 (ENSG00000151475), SLC25A4 (ENSG00000151729), SLC25A27 (ENSG00000153291), SLC25A28 (ENSG00000155287), SLC25A44 (ENSG00000160785), SLC25A45 (ENSG00000162241), SLC25A34 (ENSG00000162461), SLC25A32 (ENSG00000164933), SLC25A6 (ENSG00000169100), SLC25A33 (ENSG00000171612), SLC25A30 (ENSG00000174032), UCP3 (ENSG00000175564)
Protein
Protein identifiers
Solute carrier family 25 member 53 — Q5H9E4 (reviewed: Q5H9E4)
Alternative names: Mitochondrial carrier triple repeat protein 6
All UniProt accessions (1): Q5H9E4
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Mitochondrion inner membrane.
Similarity. Belongs to the mitochondrial carrier (TC 2.A.29) family.
RefSeq proteins (1): NP_001012773* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR018108 | MCP_transmembrane | Repeat |
| IPR023395 | MCP_dom_sf | Homologous_superfamily |
| IPR052465 | Mito_NAD+_Carrier | Family |
Pfam: PF00153
UniProt features (12 total): transmembrane region 6, repeat 3, chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5H9E4-F1 | 85.77 | 0.57 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 165 (showing top):
MORI_IMMATURE_B_LYMPHOCYTE_UP, GOBP_NUCLEOTIDE_TRANSPORT, GOLDRATH_ANTIGEN_RESPONSE, GOBP_ORGANOPHOSPHATE_ESTER_TRANSPORT, GOMF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOBP_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORT, GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_PURINE_NUCLEOTIDE_TRANSPORT, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, GOBP_TRANSMEMBRANE_TRANSPORT, GOCC_ORGANELLE_INNER_MEMBRANE, GAVIN_FOXP3_TARGETS_CLUSTER_P6, MATSUDA_NATURAL_KILLER_DIFFERENTIATION, GOMF_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY
GO Biological Process (1): NAD transmembrane transport (GO:0035352)
GO Molecular Function (1): NAD transmembrane transporter activity (GO:0051724)
GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| NAD transport | 1 |
| purine-containing compound transmembrane transport | 1 |
| nucleotide transmembrane transport | 1 |
| adenine nucleotide transmembrane transporter activity | 1 |
| NAD transmembrane transport | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
266 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC25A53 | SLC25A43 | Q8WUT9 | 677 |
| SLC25A53 | SLC25A35 | Q3KQZ1 | 614 |
| SLC25A53 | SLC25A32 | Q9H2D1 | 605 |
| SLC25A53 | SLC25A36 | Q96CQ1 | 567 |
| SLC25A53 | SLC25A33 | Q9BSK2 | 540 |
| SLC25A53 | SLC25A17 | O43808 | 530 |
| SLC25A53 | METTL22 | Q9BUU2 | 523 |
| SLC25A53 | SLC25A1 | P53007 | 489 |
| SLC25A53 | SLC25A34 | Q6PIV7 | 486 |
| SLC25A53 | SLC25A47 | Q6Q0C1 | 478 |
| SLC25A53 | CCDC160 | A6NGH7 | 467 |
| SLC25A53 | MTCH1 | Q9NZJ7 | 456 |
| SLC25A53 | SLC25A2 | Q9BXI2 | 451 |
| SLC25A53 | SLC25A30 | Q5SVS4 | 451 |
| SLC25A53 | FAM174C | Q9BVV8 | 449 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM136A | RBFOX3 | psi-mi:“MI:0914”(association) | 0.640 |
| FAM136A | PIK3C2A | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (5): SLC25A53 (Affinity Capture-MS), SLC25A53 (Affinity Capture-MS), SLC25A53 (Affinity Capture-MS), SLC25A53 (Cross-Linking-MS (XL-MS)), SLC25A53 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A2A3V2, A3LVX1, A5DIS9, A5DX39, A6ZV78, A7A285, A7TDX5, B0G159, B3LUQ6, B4F8I5, B5VI70, F4HW79, F4JU70, K7VYZ9, O13660, O94344, O94370, P15798, P39953, P40464, P40556, P43617, P53257, Q0II44, Q19529, Q20799, Q27151, Q3MHI3, Q54VX4, Q5H9E4, Q5U3V7, Q628Z2, Q6C107, Q6CQR3, Q6DHS9, Q6FTE5, Q6ZT89, Q75EP3, Q84UC7, Q86I81
Diamond homologs: A0A0G2K5L2, A0A3G9HRV8, A1CIF6, A1CWA4, A2Q9F0, A3M019, A4RPU0, A5D9W9, A6RAY2, A6S8E0, A6ZXL1, A7F9Y3, A7TIQ0, B0DK57, B0Y4J4, B2MVX9, B2VSU4, B3LH09, F4JU70, O13844, P0CAT2, Q05AQ3, Q07534, Q08CI8, Q0CT66, Q1DRJ3, Q2H608, Q2UU67, Q499U1, Q4PDL5, Q4WQC5, Q54DU1, Q54QI8, Q59KC4, Q5B717, Q5EAC0, Q5H9E4, Q5PQM9, Q6BH02, Q6C6I3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
113 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 77 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1310 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:104105192:T:A | donor_gain | 1.0000 |
| X:104156874:AAACC:A | donor_loss | 1.0000 |
| X:104156875:AACCT:A | donor_loss | 1.0000 |
| X:104156876:ACC:A | donor_loss | 1.0000 |
| X:104156877:C:CA | donor_loss | 1.0000 |
| X:104156879:T:TA | donor_gain | 1.0000 |
| X:104156920:T:A | donor_gain | 1.0000 |
| X:104112802:G:GG | donor_gain | 0.9900 |
| X:104112978:GATT:G | donor_gain | 0.9900 |
| X:104113426:C:CA | acceptor_gain | 0.9900 |
| X:104131087:T:TA | donor_gain | 0.9900 |
| X:104131137:G:C | donor_gain | 0.9900 |
| X:104156877:CCT:C | donor_gain | 0.9900 |
| X:104105167:AGG:A | donor_gain | 0.9800 |
| X:104112938:G:GT | donor_gain | 0.9800 |
| X:104113427:G:A | acceptor_gain | 0.9800 |
| X:104113432:A:AG | acceptor_gain | 0.9800 |
| X:104113433:G:GG | acceptor_gain | 0.9800 |
| X:104131088:C:A | donor_gain | 0.9800 |
| X:104156876:A:AC | donor_gain | 0.9800 |
| X:104156877:C:CC | donor_gain | 0.9800 |
| X:104113424:C:CA | acceptor_gain | 0.9700 |
| X:104156876:ACCT:A | donor_gain | 0.9700 |
| X:104156877:CCTC:C | donor_gain | 0.9700 |
| X:104104369:T:TA | donor_gain | 0.9600 |
| X:104105289:C:CC | acceptor_gain | 0.9600 |
| X:104112808:A:T | donor_gain | 0.9600 |
| X:104112997:TTAAG:T | donor_loss | 0.9600 |
| X:104112998:TAAG:T | donor_loss | 0.9600 |
| X:104112999:AAG:A | donor_loss | 0.9600 |
AlphaMissense
1981 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:104104601:A:C | S219R | 0.995 |
| X:104104601:A:T | S219R | 0.995 |
| X:104104603:T:G | S219R | 0.995 |
| X:104104970:A:C | F96L | 0.995 |
| X:104104970:A:T | F96L | 0.995 |
| X:104104972:A:G | F96L | 0.995 |
| X:104105120:A:C | F46L | 0.994 |
| X:104105120:A:T | F46L | 0.994 |
| X:104105122:A:G | F46L | 0.994 |
| X:104104679:A:C | F193L | 0.993 |
| X:104104679:A:T | F193L | 0.993 |
| X:104104681:A:G | F193L | 0.993 |
| X:104104873:C:G | A129P | 0.993 |
| X:104105099:G:C | F53L | 0.993 |
| X:104105099:G:T | F53L | 0.993 |
| X:104105101:A:G | F53L | 0.993 |
| X:104104700:G:C | S186R | 0.992 |
| X:104104700:G:T | S186R | 0.992 |
| X:104104702:T:G | S186R | 0.992 |
| X:104105108:C:A | K50N | 0.991 |
| X:104105108:C:G | K50N | 0.991 |
| X:104104408:A:G | W284R | 0.990 |
| X:104104408:A:T | W284R | 0.990 |
| X:104104896:C:T | G121E | 0.990 |
| X:104104897:C:A | G121W | 0.990 |
| X:104104670:C:A | K196N | 0.989 |
| X:104104670:C:G | K196N | 0.989 |
| X:104104691:A:C | S189R | 0.989 |
| X:104104691:A:T | S189R | 0.989 |
| X:104104693:T:G | S189R | 0.989 |
dbSNP variants (sampled 300 via entrez): RS1000501928 (X:104130734 A>G), RS1000582685 (X:104120809 A>T), RS1000650704 (X:104123502 G>A,T), RS1000950787 (X:104152109 G>A), RS1001018946 (X:104140154 A>T), RS1001201892 (X:104123399 C>T), RS1001448355 (X:104140582 C>A,T), RS1001653187 (X:104131420 G>A), RS1001684511 (X:104132000 A>G), RS1001846687 (X:104139430 T>C), RS1001917992 (X:104141684 C>T), RS1001995265 (X:104129391 A>G), RS1002087346 (X:104120224 A>G), RS1002152086 (X:104122915 G>A), RS1002426559 (X:104129839 C>T)
Disease associations
OMIM: gene MIM:300941 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — Miscellaneous SLC25 mitochondrial transporters
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, increases methylation | 4 |
| mercuric bromide | decreases expression, affects cotreatment | 2 |
| Panobinostat | affects cotreatment, decreases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| beta-lapachone | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | increases methylation, affects methylation | 1 |
| Ketoconazole | decreases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Urethane | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4KJ | HCT116-SLC25A53-KO-c2 | Cancer cell line | Male |
| CVCL_D4KK | HCT116-SLC25A53-KO-c30 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.